Search for Clinical Trial Results

Sponsored By

Lymphoblastic Lymphoma - 24 Studies Found

Status Study
Completed Study Name: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
Condition: Lymphoma, Lymphoblastic
Date: 2015-03-18
Interventions:
  • Drug: induction

Completed Study Name: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
Condition:
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma Date: 2016-05-03
    Interventions:
    • Drug: BL-8040
    • Drug: Nelarabine

Terminated Study Name: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Condition:
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma

Date: 2014-09-22
Interventions: Drug: pegcrisantaspase
Active, not recruiting Study Name: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Condition:
  • Lymphoblastic Leukemia, Acute T-cell
  • Precursor T-Cell Lymphoblastic Ly
    Date: 2011-04-22
    Interventions:
    • Drug: BMS-906024 Other Name: N
Completed Study Name: Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma
Condition:
  • Leukemia
  • Lymphoblastic Lymphoma
  • Drug: Doxorubicin

Completed Study Name: LBL-2016 for Children or Adolescents in China
Condition: Lymphoblastic Lymphoma
Date: 2016-07-24
Interventions:
  • Drug: Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosp
Completed Study Name: Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath
Condition:
  • Adult Acute Lymphocytic Leukemia T-Cell
  • Lymphoma, Lymphoblastic
    Date: 2005-09-12
    Interventions:
    • Drug: Alemtuzumab (MabCampath)
    • Drug: Cladr
Recruiting Study Name: Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Condition:
  • Leukemia
  • Precursor-B Acute Lymphoblastic Leukemia
  • Date: 2015-04-14
    Interventions:
    • Drug: Cytarabine

Not yet recruiting Study Name: Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
Condition:
  • Hematopoietic/Lymphoid Cancer
  • Acute Lymphoblastic Leukemia
  • Date: 2017-04-27
    Interventions:
    • Drug: Clofarabine

Withdrawn Study Name: An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
Condition:
Date: 2025-11-04
<<< Previous | Next >>>